This website uses cookies to ensure you get the best experience. Learn more about DOAJ’s privacy policy.
Hide this message
PLoS ONE (Jan 2018)
Affiliations
Read online
CONCLUSION:The mT/N1 ratio, PAD, and AAD can be used as predictors of tumor response to SIRT treatment, and SPECT/CT imaging can be used for dosimetric assessment of radioembolization.